Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP8B1 | Q9UNU6 | 1/20 | 0.47 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.43 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.42 |
| ▸ | IDO1 | P14902 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | TACR2 | P21452 | 1/20 | 0.38 |
| ▸ | HMOX1 | P09601 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6579819 | 0.79 | CYP8B1 (0.49) | CYP8B1CYP19A1ADRA2CIDO1ALOX15 | |
| SCHEMBL6577340 | 0.79 | CYP8B1 (0.49) | CYP8B1CYP19A1ADRA2CIDO1ALOX15 | |
| SCHEMBL6581686 | 0.79 | CYP8B1 (0.49) | CYP8B1CYP19A1ADRA2CIDO1ALOX15 | |
| SCHEMBL8128032 | 0.79 | CYP19A1 (0.52) | CYP8B1CYP19A1ADRA2CIDO1ALOX15 | |
| SCHEMBL11270380 | 0.76 | CYP19A1 (0.62) | CYP8B1CYP19A1ADRA2CHMOX1 | |
| SCHEMBL6579695 | 0.76 | CYP8B1 (0.48) | CYP8B1CYP19A1ADRA2CIDO1ALOX15 | |
| SCHEMBL6576990 | 0.76 | CYP8B1 (0.48) | CYP8B1CYP19A1ADRA2CIDO1ALOX15 | |
| SCHEMBL6577049 | 0.76 | CYP8B1 (0.48) | CYP8B1CYP19A1ADRA2CIDO1ALOX15 | |
| SCHEMBL6579992 | 0.76 | CYP8B1 (0.48) | CYP8B1CYP19A1ADRA2CIDO1ALOX15 | |
| SCHEMBL6577046 | 0.76 | CYP8B1 (0.48) | CYP8B1CYP19A1ADRA2CIDO1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0994876-B1 | QUATERNARY AMMONIUM COMPOUNDS AS TACHYKININ ANTAGONISTS | PFIZER LTD (GB) | 2004-09-08 | — | — | EP | disclosed |
| US-6380396-B1 | CHEMICAL INTERMEDIATES FOR ANTIINFLAMMATORY AGENTS | PFIZER INC. | 2002-04-30 | — | — | US | disclosed |
| US-6207678-B1 | USED FOR TREATING INFLAMMATORY DISEASE SUCH AS ARTHRITIS, PSORIASIS, ASTHMA OR INFLAMMATORY BOWEL DISEASE, CENTRAL NERVOUS SYSTEM DISORDER SUCH AS ANXIETY, DEPRESSION, DEMENTIA OR PSYCHOSIS, GASTROINTESTINAL DISORDERS | PFIZER INC | 2001-03-27 | — | — | US | disclosed |
| EP-0994876-A1 | QUATERNARY AMMONIUM COMPOUNDS AS TACHYKININ ANTAGONISTS | Pfizer Limited (GB) | 2000-04-26 | — | — | EP | disclosed |
| WO-1998057972-A1 | QUATERNARY AMMONIUM COMPOUNDS AS TACHYKININ ANTAGONISTS | PFIZER LIMITED (GB) | 1998-12-23 | — | — | WO | disclosed |